Zobrazeno 1 - 10
of 114
pro vyhledávání: '"Yavuz Ozisik"'
Autor:
Gökmen Umut Erdem, Ali R Sever, Yavuz Ozisik, Fatih Karatas, Aydin Aytekin, Kadri Altundag, Suleyman Sahin
Publikováno v:
The Breast. 32:227-236
Background:Body mass index (BMI) is defined as a poor prognostic factor in patients with breast cancer(BC). However, there are controversial results regarding the various effects of BMI on BC, hence the exactpathophysiology of the relation between ob
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b0732c244c9b520f9a31e3e7049d4e4b
https://doi.org/10.1016/j.breast.2016.09.019
https://doi.org/10.1016/j.breast.2016.09.019
Autor:
Gökmen Umut Erdem, Ozturk Ates, Sercan Aksoy, Aydin Aytekin, Suleyman Sahin, Yavuz Ozisik, Kadri Altundag, Fatih Karatas
Publikováno v:
Journal of Cancer Research and Therapeutics, Vol 14, Iss 6, Pp 1184-1190 (2018)
Introduction: The relation between Behçet's disease (BD) and breast cancer (BC) is unclear. Our purpose is to investigate whether BD has an important effect on BC or vice versa. Patients and Methods: A total of 12 female BC patients with a diagnosis
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e86f1893cdcbdf2c737898ebd1e86b04
https://pubmed.ncbi.nlm.nih.gov/30488827
https://pubmed.ncbi.nlm.nih.gov/30488827
Publikováno v:
Cancer Research. 75:P1-12
Introduction: Obesity is an independent risk factor for the development of breast cancer and has been associated with poor breast cancer outcomes. But, this association usually depend on hormone-receptor positivity and ovarian activity. Obesity was c
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::41b6e446d3ffdf249a95a213d4db22fb
https://doi.org/10.1158/1538-7445.sabcs14-p1-12-16
https://doi.org/10.1158/1538-7445.sabcs14-p1-12-16
Autor:
Fatih, Karatas, Sanja, Sahin, Gokmen U, Erdem, Ozturk, Ates, Taner, Babacan, Serkan, Akin, Ali R, Sever, Yavuz, Ozisik, Kadri, Altundag
Publikováno v:
Journal of B.U.ON. : official journal of the Balkan Union of Oncology. 21(4)
Development of metastasis in patients with breast cancer (BC) is the most important negative prognostic factor and this process mainly begins with lymphatic involvement. Therefore, axillary, subclavicular, internal mammary or supraclavicular nodal in
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::f39d59f678c162fe3cb37bd77c99ce99
https://pubmed.ncbi.nlm.nih.gov/27685905
https://pubmed.ncbi.nlm.nih.gov/27685905
Autor:
Mehmet, Ozen, Mehmet, Gunduz, Ozturk, Ates, Taner, Babacan, Ali R, Sever, Serkan, Akin, Yavuz, Ozisik, Kadri, Altundag
Publikováno v:
Journal of B.U.ON. : official journal of the Balkan Union of Oncology. 21(4)
Optimal duration of adjuvant trastuzumab therapy in early-stage HER2-positive, lymph node-negative breast cancer is unknown. To establish this, we compared 1-year and 9-week trastuzumab regimens in HER2-positive, lymph node-negative early-stage breas
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::bea8d294336e3bd1fee8e855f0f5a890
https://pubmed.ncbi.nlm.nih.gov/27685899
https://pubmed.ncbi.nlm.nih.gov/27685899
Autor:
Yavuz Ozisik, Dincer Firat, Nilüfer Güler, Ibrahim Gullu, Ayse Kars, Ibrahim Barista, Semra Dündar, Emin Kansu, Nurullah Zengin, Oktay Özdemir
Publikováno v:
Hematology (Amsterdam, Netherlands). 2(2)
Staging systems are essential for understanding disease, in predicting the outcome, and therapeutic decision making in any tumor as well as chronic lymphocytic leukemia (CLL). In this study, we compared the clinical correlation of the Rai and Binet c
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ea54d274d55d3835bf8203166fed79f6
https://pubmed.ncbi.nlm.nih.gov/27406802
https://pubmed.ncbi.nlm.nih.gov/27406802
Autor:
Ozturk, Ates, Taner, Babacan, Neyran, Kertmen, Furkan, Sarici, Alma, Cenoli, Serkan, Akin, Yusuf, Karakas, Saadettin, Kilickap, Yavuz, Ozisik, Ali R, Sever, Sercan, Aksoy, Kadri, Altundag
Publikováno v:
Journal of B.U.ON. : official journal of the Balkan Union of Oncology. 21(2)
Eribulin is a non-taxane microtubule inhibitor, which can be used after anthracycline and taxane treatment in patients with metastatic breast cancer (MBC). The purpose of this study was to investigate the efficacy and safety of eribulin monotherapy i
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::2d4c1d610193fe0920d9223bd4172f8d
https://pubmed.ncbi.nlm.nih.gov/27273947
https://pubmed.ncbi.nlm.nih.gov/27273947
Autor:
Yavuz Ozisik, Gökmen Umut Erdem, Deniz Yuce, Ozturk Ates, Kadri Altundag, Aydin Aytekin, Ali R Sever, Suleyman Sahin, Taner Babacan, Fatih Karatas
Publikováno v:
Breast (Edinburgh, Scotland). 32
Purpose The relation between higher body mass index (BMI) and pathological complete response (pCR) to neoadjuvant chemotherapy (NAC) in breast cancer (BC) is a controversial issue according to the data of Western and Asian patients. The aim of this s
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1bd5ac9da35b05f5d257f286b0dd7c21
https://pubmed.ncbi.nlm.nih.gov/27318645
https://pubmed.ncbi.nlm.nih.gov/27318645
Publikováno v:
Breast Disease ISBN: 9783319228426
Breast Disease ISBN: 9783030046057
Breast Disease ISBN: 9783030046057
In clinical practice, although local recurrence or distant metastasis develops in some individuals who have been assessed as low risk despite treatment, some individuals with high-risk disease do not relapse despite systemic and local therapy. Theref
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1cc51432227113621f69986b2f749e74
https://doi.org/10.1007/978-3-319-22843-3_12
https://doi.org/10.1007/978-3-319-22843-3_12
Publikováno v:
Breast Disease ISBN: 9783319228426
Breast Disease ISBN: 9783030046057
Breast Disease ISBN: 9783030046057
Among women, breast cancer accounts for one-third of cancer cases and is the second most frequent cause of death. Improvements in treatment agents and screening procedures have increased the diagnosis of early breast cancer and survival rates. Adjuva
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::26c921f60a45aa7acaa123e029205291
https://doi.org/10.1007/978-3-319-22843-3_11
https://doi.org/10.1007/978-3-319-22843-3_11